Treatment Options for Intrahepatic Bile Duct Cancer
Intrahepatic bile duct cancer (also called intrahepatic cholangiocarcinoma) is a rare cancer that starts in the part of the bile duct that is inside the liver. The objective of treatment for intrahepatic bile duct cancer includes:
- Curative Treatment: The goal of curative treatment is to remove the tumor and all cancerous tissue.
- Slowing Progression: Certain treatments can help slow down the progression of intrahepatic bile duct cancer.
- Symptom Control: Palliative therapy aims to relieve symptoms and improve quality of life for individuals with advanced or unresectable cancer.
It's important to note that treatment plans are individualized based on factors such as the stage and extent of the cancer, overall health status, and patient preferences. Consulting with a healthcare professional is crucial in determining the most appropriate treatment approach for intrahepatic bile duct cancer.
The choice of treatment depends on various factors, including the individual's specific condition and the stage of their cancer. It is always recommended to consult with a doctor to determine the most appropriate treatment plan. Potential treatment options for intrahepatic bile duct cancer include:
- Surgery: Surgery is often the initial treatment for intrahepatic bile duct cancer. The goal of surgery is to remove the cancerous tumor and achieve negative margins, which means removing all cancer cells. The extent of surgery required depends on the involvement of the liver and proximity of the tumor to major blood vessels. In some cases, preoperative portal vein embolization may be considered to optimize the volume of the remaining liver.
- Adjuvant Therapy: Adjuvant therapy refers to additional treatments given after surgery to reduce the risk of cancer recurrence. It may include radiation therapy or chemotherapy. Radiation therapy uses high-energy beams to target and destroy cancer cells, while chemotherapy uses medications to kill cancer cells throughout the body.
- Targeted Drug Therapy: Targeted drug therapy is a type of treatment that specifically targets certain molecules or pathways involved in cancer growth. For example, pemigatinib is a targeted therapy approved by the FDA for advanced cholangiocarcinoma with FGFR2 fusion or rearrangement.
- Immunotherapy: Immunotherapy is a form of treatment that harnesses the power of the immune system to fight cancer cells. It works by stimulating or enhancing the body's immune response against cancer. While immunotherapy is still being investigated for bile duct cancer, there are emerging options such as CAR T-cell therapy, which involves genetically modifying a person's own immune cells (T cells) to recognize and attack cancer cells.
It's important to note that each individual's treatment plan may vary based on their specific circumstances and medical evaluation. Therefore, it is crucial to consult with a healthcare professional who can provide personalized recommendations and guidance regarding potential treatments for intrahepatic bile duct cancer.